Mikhail Sumin

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Baseline Characteristics of Patients Enrolled in the EMPACT-MI Trial”.

Baseline Characteristics of Patients Enrolled in the EMPACT-MI Trial

European Journal of Heart Failure(2023)10.1002/ejhf.2990

N/A

0DataRank · unranked

21 citations

Jacob A. Udell, W. Schuyler Jones, Stefan D. Anker, Deepak L. Bhatt, Mark C. Petrie +6 more

Secondary analysis of the EMPACT-MI trial reveals cardiovascular–kidney efficacy and safety of empagliflozin after acute myocardial infarction

Nature Cardiovascular Research(2025)10.1038/s44161-025-00657-7

N/A

0DataRank · unranked

3 citations

Deepak L. Bhatt, Adrian F. Hernandez, Stefan D. Anker, Josephine Harrington, W. Schuyler Jones +8 more

Empagliflozin After Myocardial Infarction with or without diabetes and chronic kidney disease: Insights from EMPACT-MI

ESC Heart Failure(2025)10.1002/ehf2.15393

N/A

0DataRank · unranked

1 citations

Javed Butler, Jacob A. Udell, W. Schuyler Jones, Mark C. Petrie, Josephine Harrington +19 more